Evidence map›Paper›PMID 36615052›Full record

ArticleJournal of clinical medicine2022

Phosphaturic Mesenchymal Tumors: Rethinking the Clinical Diagnosis and Surgical Treatment.

Yupeng Liu, Hongbo He, Can Zhang, Hao Zeng, Xiaopeng Tong, Qing Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yupeng LiuDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.
Hongbo HeDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.
Can ZhangDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.
Hao ZengDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.
Xiaopeng TongDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.
Qing LiuDepartment of Orthopaedics, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha 410008, China.ORCID 0000-0003-1098-5475
Central South University · CN

Funding

Changsha Natural Science Foundation kq2202382the Natural Science Foundation of Hunan 2021JJ31085the Natural Science Foundation of Hunan 2022JJ30928the Natural Science Foundation of Hunan 2022JJ40802the Project funded by China Postdoctoral Science Foundation 2022M713525
6 · The paper itself

Abstract

backgroundThe diagnosis of phosphaturic mesenchymal tumors (PMT) is easily delayed clinically, and their surgical treatment is unstandardized. This study aimed to evaluate our experience in the diagnosis and treatment of PMT and provide a research basis for the accurate and standardized treatment of PMT. MATERIALS AND

methodsTwelve patients diagnosed with PMT in our department and who underwent surgical treatment were included in this study. Preoperative demographic and clinical information were recorded. CT, MRI, and technetium-99m (Tc99m)-octreotide PET/CT imaging techniques were used to evaluate the general conditions and lesion boundaries of the tumors. Surgical treatment was performed using radical resection and microwave ablation-assisted extended curettage according to the lesion location and size. Patients were strictly followed up with and evaluated for oncological prognosis, radiological results, bone healing, serum ion levels, limb function, and pain level; the occurrence of complications was also recorded.

resultsThree patients underwent radical resection, and nine underwent microwave ablation-assisted extended curettage. The average duration of symptoms in this group was 1.5 years (9-35 months) before diagnosis. Serum phosphate and AKP levels returned to normal one and two weeks postoperatively, respectively. There was no apparent specificity in the pathological findings; however, the immunohistochemistry of FGF-23 was positive, and the original fracture sites were effectively healed during the follow-up. The limb function and pain scores were significantly improved. The MSTS score increased from 15.3 to 29.0, and the VAS score decreased from 5.3 to 0.4. All patients recovered, and 90% resumed their original jobs.

conclusionsAccurate diagnosis and standardized surgical treatment are crucial to achieving a clinical cure for PMT. Combining clinical manifestations, biochemical examinations, imaging characteristics, and pathological findings is an effective way to diagnose PMT accurately. Radical resection and microwave ablation-assisted extended curettage are reliable surgical treatment methods for PMT.

Indexed as

FGF-23hypophosphataemiaphosphaturic mesenchymal tumorsTc99m-octreotide PET/CTtumor-induced osteomalacia

Identifiers

PMID36615052
PMCPMC9821698
OpenAlexW4313327798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.